Craniotomy for brain tumor

Kenneth Hill Jr., Jeffrey J. Olson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Brain tumors have been loosely divided between primary (occurring from the cells native to the CNS) and secondary or metastatic (from spread by direct contiguous contact or hematologic spread). The incidence of primary brain tumors in the USA is roughly 6.4 for every 100,000 people, with the majority comprising the glioblastoma subtype. Metastatic brain tumors occur in 15–20% of all cancer patients with the primary etiology being lung, breast, melanoma, and renal tumors. With the development of new imaging techniques, innovative surgical techniques, and progressive adjunctive therapies, the treatment of brain tumors now involves earlier diagnosis, improved accuracy for surgery, and more medical and radiation options for patients with brain tumors. Despite improved imaging techniques that can better describe the characteristics of brain tumors without tissue evaluation, the role of craniotomy surgery is an important component of both diagnosis and treatment of patients with brain tumors. As opposed to formal craniotomy, stereotactic needle biopsy can be used for those patients with tumor in a deep, functionally important region of the brain and in patients with poor systemic health. Histologic examination of these core needle biopsies is then used to direct therapy. Craniotomy and surgical debulking/excision are especially beneficial in those patients with large lesions that are symptomatic due to size and edema that cause compression of surrounding brain tissue. Preoperative imaging for brain tumors is technically specific to each individual patient. With expert interpretation, surgical planning can be made with a general understanding of the goal of the procedure. Imaging techniques have progressed to include digital subtraction angiography, MRI, MR spectroscopy and functional MRI, to name a few. These techniques provide valuable information, but are frequently unable to exclude all other non-tumorous lesions like infarction, infection, and multiple sclerosis. Thus a craniotomy or needle biopsy is required to obtain definitive diagnosis.

Original languageEnglish (US)
Title of host publicationMedical Management of the Surgical Patient
Subtitle of host publicationA Textbook of Perioperative Medicine, Fifth Edition
PublisherCambridge University Press
Pages665-669
Number of pages5
ISBN (Electronic)9780511920660
ISBN (Print)9781107009165
DOIs
StatePublished - Jan 1 2010

Fingerprint

Craniotomy
Brain Neoplasms
Needle Biopsy
Large-Core Needle Biopsy
Neoplasms
Digital Subtraction Angiography
Brain
Therapeutics
Glioblastoma
Infarction
Multiple Sclerosis
Names
Early Diagnosis
Melanoma
Edema
Breast
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Radiation
Kidney

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hill Jr., K., & Olson, J. J. (2010). Craniotomy for brain tumor. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition (pp. 665-669). Cambridge University Press. https://doi.org/10.1017/CBO9780511920660.106
Hill Jr., Kenneth ; Olson, Jeffrey J. / Craniotomy for brain tumor. Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. pp. 665-669
@inbook{4147b24b3bf9470abecde591170cfc5d,
title = "Craniotomy for brain tumor",
abstract = "Brain tumors have been loosely divided between primary (occurring from the cells native to the CNS) and secondary or metastatic (from spread by direct contiguous contact or hematologic spread). The incidence of primary brain tumors in the USA is roughly 6.4 for every 100,000 people, with the majority comprising the glioblastoma subtype. Metastatic brain tumors occur in 15–20{\%} of all cancer patients with the primary etiology being lung, breast, melanoma, and renal tumors. With the development of new imaging techniques, innovative surgical techniques, and progressive adjunctive therapies, the treatment of brain tumors now involves earlier diagnosis, improved accuracy for surgery, and more medical and radiation options for patients with brain tumors. Despite improved imaging techniques that can better describe the characteristics of brain tumors without tissue evaluation, the role of craniotomy surgery is an important component of both diagnosis and treatment of patients with brain tumors. As opposed to formal craniotomy, stereotactic needle biopsy can be used for those patients with tumor in a deep, functionally important region of the brain and in patients with poor systemic health. Histologic examination of these core needle biopsies is then used to direct therapy. Craniotomy and surgical debulking/excision are especially beneficial in those patients with large lesions that are symptomatic due to size and edema that cause compression of surrounding brain tissue. Preoperative imaging for brain tumors is technically specific to each individual patient. With expert interpretation, surgical planning can be made with a general understanding of the goal of the procedure. Imaging techniques have progressed to include digital subtraction angiography, MRI, MR spectroscopy and functional MRI, to name a few. These techniques provide valuable information, but are frequently unable to exclude all other non-tumorous lesions like infarction, infection, and multiple sclerosis. Thus a craniotomy or needle biopsy is required to obtain definitive diagnosis.",
author = "{Hill Jr.}, Kenneth and Olson, {Jeffrey J.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511920660.106",
language = "English (US)",
isbn = "9781107009165",
pages = "665--669",
booktitle = "Medical Management of the Surgical Patient",
publisher = "Cambridge University Press",
address = "United Kingdom",

}

Hill Jr., K & Olson, JJ 2010, Craniotomy for brain tumor. in Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, pp. 665-669. https://doi.org/10.1017/CBO9780511920660.106

Craniotomy for brain tumor. / Hill Jr., Kenneth; Olson, Jeffrey J.

Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. p. 665-669.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Craniotomy for brain tumor

AU - Hill Jr., Kenneth

AU - Olson, Jeffrey J.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Brain tumors have been loosely divided between primary (occurring from the cells native to the CNS) and secondary or metastatic (from spread by direct contiguous contact or hematologic spread). The incidence of primary brain tumors in the USA is roughly 6.4 for every 100,000 people, with the majority comprising the glioblastoma subtype. Metastatic brain tumors occur in 15–20% of all cancer patients with the primary etiology being lung, breast, melanoma, and renal tumors. With the development of new imaging techniques, innovative surgical techniques, and progressive adjunctive therapies, the treatment of brain tumors now involves earlier diagnosis, improved accuracy for surgery, and more medical and radiation options for patients with brain tumors. Despite improved imaging techniques that can better describe the characteristics of brain tumors without tissue evaluation, the role of craniotomy surgery is an important component of both diagnosis and treatment of patients with brain tumors. As opposed to formal craniotomy, stereotactic needle biopsy can be used for those patients with tumor in a deep, functionally important region of the brain and in patients with poor systemic health. Histologic examination of these core needle biopsies is then used to direct therapy. Craniotomy and surgical debulking/excision are especially beneficial in those patients with large lesions that are symptomatic due to size and edema that cause compression of surrounding brain tissue. Preoperative imaging for brain tumors is technically specific to each individual patient. With expert interpretation, surgical planning can be made with a general understanding of the goal of the procedure. Imaging techniques have progressed to include digital subtraction angiography, MRI, MR spectroscopy and functional MRI, to name a few. These techniques provide valuable information, but are frequently unable to exclude all other non-tumorous lesions like infarction, infection, and multiple sclerosis. Thus a craniotomy or needle biopsy is required to obtain definitive diagnosis.

AB - Brain tumors have been loosely divided between primary (occurring from the cells native to the CNS) and secondary or metastatic (from spread by direct contiguous contact or hematologic spread). The incidence of primary brain tumors in the USA is roughly 6.4 for every 100,000 people, with the majority comprising the glioblastoma subtype. Metastatic brain tumors occur in 15–20% of all cancer patients with the primary etiology being lung, breast, melanoma, and renal tumors. With the development of new imaging techniques, innovative surgical techniques, and progressive adjunctive therapies, the treatment of brain tumors now involves earlier diagnosis, improved accuracy for surgery, and more medical and radiation options for patients with brain tumors. Despite improved imaging techniques that can better describe the characteristics of brain tumors without tissue evaluation, the role of craniotomy surgery is an important component of both diagnosis and treatment of patients with brain tumors. As opposed to formal craniotomy, stereotactic needle biopsy can be used for those patients with tumor in a deep, functionally important region of the brain and in patients with poor systemic health. Histologic examination of these core needle biopsies is then used to direct therapy. Craniotomy and surgical debulking/excision are especially beneficial in those patients with large lesions that are symptomatic due to size and edema that cause compression of surrounding brain tissue. Preoperative imaging for brain tumors is technically specific to each individual patient. With expert interpretation, surgical planning can be made with a general understanding of the goal of the procedure. Imaging techniques have progressed to include digital subtraction angiography, MRI, MR spectroscopy and functional MRI, to name a few. These techniques provide valuable information, but are frequently unable to exclude all other non-tumorous lesions like infarction, infection, and multiple sclerosis. Thus a craniotomy or needle biopsy is required to obtain definitive diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=84923490447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923490447&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511920660.106

DO - 10.1017/CBO9780511920660.106

M3 - Chapter

SN - 9781107009165

SP - 665

EP - 669

BT - Medical Management of the Surgical Patient

PB - Cambridge University Press

ER -

Hill Jr. K, Olson JJ. Craniotomy for brain tumor. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press. 2010. p. 665-669 https://doi.org/10.1017/CBO9780511920660.106